CLAY B SIEGALL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).
Latest Insider Trading Transactions of CLAY B SIEGALL
Sentiment: All, ALDR, SGEN, SYBX, RARE
Page: < prev 1 ... 3 4 5 6 7 8 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 40.05 | 2,700 | 108,130 | 525,217 | 527.9 K to 525.2 K (-0.51 %) |
| Aug 13 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.92 | 2,700 | 15,984 | 527,917 | 525.2 K to 527.9 K (+0.51 %) |
| Jun 12 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 5.92 | 11,200 | 66,304 | 33,604 | |
| Jun 12 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 40.14 | 11,200 | 449,574 | 525,217 | 536.4 K to 525.2 K (-2.09 %) |
| Jun 12 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.92 | 11,200 | 66,304 | 536,417 | 525.2 K to 536.4 K (+2.13 %) |
| Jun 12 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Gift | G | 0.00 | 325,479 | 0 | 525,217 | 850.7 K to 525.2 K (-38.26 %) |
| Jun 12 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 1,038,554 | 1 M to 1 M (-0.48 %) |
| Apr 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 5.92 | 5,600 | 33,152 | 44,804 | |
| Apr 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 43.34 | 5,600 | 242,702 | 955,696 | 961.3 K to 955.7 K (-0.58 %) |
| Apr 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.92 | 5,600 | 33,152 | 961,296 | 955.7 K to 961.3 K (+0.59 %) |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 5.92 | 5,600 | 33,152 | 50,404 | |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 5.63 | 3,718 | 20,932 | 78,080 | |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 52.89 | 5,600 | 296,164 | 955,696 | 961.3 K to 955.7 K (-0.58 %) |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.92 | 5,600 | 33,152 | 961,296 | 955.7 K to 961.3 K (+0.59 %) |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 52.89 | 3,718 | 196,632 | 955,696 | 959.4 K to 955.7 K (-0.39 %) |
| Mar 07 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.63 | 3,718 | 20,932 | 959,414 | 955.7 K to 959.4 K (+0.39 %) |
| Feb 18 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 12,142 | 125,427 | 0 | |
| Feb 18 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 51.97 | 100,000 | 5,197,010 | 955,696 | 1.1 M to 955.7 K (-9.47 %) |
| Feb 18 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 12,142 | 125,427 | 1,055,696 | 1 M to 1.1 M (+1.16 %) |
| Jan 06 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 1,858 | 19,193 | 0 | |
| Jan 06 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 39.27 | 1,858 | 72,957 | 1,043,554 | 1 M to 1 M (-0.18 %) |
| Jan 06 2014 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 1,858 | 19,193 | 1,045,412 | 1 M to 1 M (+0.18 %) |
| Dec 09 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 5.92 | 18,996 | 112,456 | 0 | |
| Dec 09 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 5.92 | 18,996 | 112,456 | 1,043,554 | 1 M to 1 M (+1.85 %) |
| Dec 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 1,858 | |
| Dec 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 41.25 | 2,000 | 82,492 | 1,024,558 | 1 M to 1 M (-0.19 %) |
| Dec 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,026,558 | 1 M to 1 M (+0.20 %) |
| Nov 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 3,858 | |
| Nov 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 38.63 | 2,000 | 77,254 | 1,024,558 | 1 M to 1 M (-0.19 %) |
| Nov 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,026,558 | 1 M to 1 M (+0.20 %) |
| Oct 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 5,858 | |
| Oct 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 43.87 | 2,000 | 87,732 | 1,024,558 | 1 M to 1 M (-0.19 %) |
| Oct 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,026,558 | 1 M to 1 M (+0.20 %) |
| Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 7,858 | |
| Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 43.92 | 100,000 | 4,392,270 | 977,211 | 1.1 M to 977.2 K (-9.28 %) |
| Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 42.77 | 2,000 | 85,532 | 1,077,211 | 1.1 M to 1.1 M (-0.19 %) |
| Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,079,211 | 1.1 M to 1.1 M (+0.19 %) |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 41.04 | 135,064 | 5,543,027 | 135,064 | |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 41.04 | 2,436 | 99,973 | 2,436 | |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 55,000 | 0 | 1,124,558 | 1.1 M to 1.1 M (+5.14 %) |
| Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 40.91 | 7,653 | 313,084 | 1,069,558 | 1.1 M to 1.1 M (-0.71 %) |
| Aug 02 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 9,858 | |
| Aug 02 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 40.03 | 2,000 | 80,063 | 1,077,211 | 1.1 M to 1.1 M (-0.19 %) |
| Aug 02 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,079,211 | 1.1 M to 1.1 M (+0.19 %) |
| Jul 02 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 11,858 | |
| Jul 02 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 32.59 | 2,000 | 65,186 | 1,077,211 | 1.1 M to 1.1 M (-0.19 %) |
| Jul 02 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,079,211 | 1.1 M to 1.1 M (+0.19 %) |
| Jun 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 13,858 | |
| Jun 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 33.88 | 2,000 | 67,762 | 1,077,211 | 1.1 M to 1.1 M (-0.19 %) |
| Jun 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,079,211 | 1.1 M to 1.1 M (+0.19 %) |
| May 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 15,858 | |
| May 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 36.58 | 2,000 | 73,153 | 1,077,211 | 1.1 M to 1.1 M (-0.19 %) |
| May 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,079,211 | 1.1 M to 1.1 M (+0.19 %) |
| Apr 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 17,858 | |
| Apr 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 35.53 | 2,000 | 71,062 | 1,077,211 | 1.1 M to 1.1 M (-0.19 %) |
| Apr 03 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,079,211 | 1.1 M to 1.1 M (+0.19 %) |
| Mar 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 19,858 | |
| Mar 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 28.87 | 68,750 | 1,984,950 | 1,077,211 | 1.1 M to 1.1 M (-6.00 %) |
| Mar 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 28.31 | 25,000 | 707,820 | 1,145,961 | 1.2 M to 1.1 M (-2.13 %) |
| Mar 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 28.12 | 2,000 | 56,247 | 1,170,961 | 1.2 M to 1.2 M (-0.17 %) |
| Mar 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,172,961 | 1.2 M to 1.2 M (+0.17 %) |
| Feb 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 21,858 | |
| Feb 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 29.61 | 2,000 | 59,216 | 1,170,961 | 1.2 M to 1.2 M (-0.17 %) |
| Feb 05 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,172,961 | 1.2 M to 1.2 M (+0.17 %) |
| Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 23,858 | |
| Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 6,249 | 20,622 | 0 | |
| Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 25.05 | 2,000 | 50,104 | 1,170,961 | 1.2 M to 1.2 M (-0.17 %) |
| Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,172,961 | 1.2 M to 1.2 M (+0.17 %) |
| Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 23.83 | 6,249 | 148,939 | 1,170,961 | 1.2 M to 1.2 M (-0.53 %) |
| Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 6,249 | 20,622 | 1,177,210 | 1.2 M to 1.2 M (+0.53 %) |
| Dec 04 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 8,250 | 27,225 | 4,249 | |
| Dec 04 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 25.19 | 8,250 | 207,777 | 1,170,961 | 1.2 M to 1.2 M (-0.70 %) |
| Dec 04 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 8,250 | 27,225 | 1,179,211 | 1.2 M to 1.2 M (+0.70 %) |
| Nov 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 27,858 | |
| Nov 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 6,250 | 20,625 | 12,499 | |
| Nov 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 25.51 | 2,000 | 51,025 | 1,170,961 | 1.2 M to 1.2 M (-0.17 %) |
| Nov 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,172,961 | 1.2 M to 1.2 M (+0.17 %) |
| Nov 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 25.51 | 6,250 | 159,452 | 1,170,961 | 1.2 M to 1.2 M (-0.53 %) |
| Nov 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 6,250 | 20,625 | 1,177,211 | 1.2 M to 1.2 M (+0.53 %) |
| Oct 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 29,858 | |
| Oct 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 6,250 | 20,625 | 18,749 | |
| Oct 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 26.59 | 2,000 | 53,174 | 1,170,961 | 1.2 M to 1.2 M (-0.17 %) |
| Oct 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,172,961 | 1.2 M to 1.2 M (+0.17 %) |
| Oct 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 26.59 | 6,250 | 166,170 | 1,170,961 | 1.2 M to 1.2 M (-0.53 %) |
| Oct 02 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 6,250 | 20,625 | 1,177,211 | 1.2 M to 1.2 M (+0.53 %) |
| Sep 06 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 31,858 | |
| Sep 06 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 6,250 | 20,625 | 24,999 | |
| Sep 06 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 26.54 | 2,000 | 53,081 | 1,170,961 | 1.2 M to 1.2 M (-0.17 %) |
| Sep 06 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,172,961 | 1.2 M to 1.2 M (+0.17 %) |
| Sep 06 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 26.54 | 6,250 | 165,878 | 1,170,961 | 1.2 M to 1.2 M (-0.53 %) |
| Sep 06 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 6,250 | 20,625 | 1,177,211 | 1.2 M to 1.2 M (+0.53 %) |
| Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 26.10 | 181,794 | 4,744,823 | 181,794 | |
| Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 26.10 | 3,831 | 99,989 | 3,831 | |
| Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 74,250 | 0 | 1,170,961 | 1.1 M to 1.2 M (+6.77 %) |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 33,858 | |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 458 | 1,511 | 31,249 | |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 5,792 | 19,114 | 31,707 | |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 25.22 | 458 | 11,550 | 1,096,711 | 1.1 M to 1.1 M (-0.04 %) |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 458 | 1,511 | 1,097,169 | 1.1 M to 1.1 M (+0.04 %) |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 26.04 | 2,000 | 52,082 | 1,096,711 | 1.1 M to 1.1 M (-0.18 %) |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,098,711 | 1.1 M to 1.1 M (+0.18 %) |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 26.04 | 5,792 | 150,829 | 1,096,711 | 1.1 M to 1.1 M (-0.53 %) |
| Aug 03 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 5,792 | 19,114 | 1,102,503 | 1.1 M to 1.1 M (+0.53 %) |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Option Exercise | M | 10.33 | 2,000 | 20,660 | 35,858 | |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Option Exercise | M | 3.30 | 6,250 | 20,625 | 37,499 | |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Sell | S | 25.36 | 2,000 | 50,715 | 1,096,711 | 1.1 M to 1.1 M (-0.18 %) |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Buy | M | 10.33 | 2,000 | 20,660 | 1,098,711 | 1.1 M to 1.1 M (+0.18 %) |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Sell | S | 25.36 | 6,250 | 158,486 | 1,096,711 | 1.1 M to 1.1 M (-0.57 %) |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Buy | M | 3.30 | 6,250 | 20,625 | 1,102,961 | 1.1 M to 1.1 M (+0.57 %) |
| Jul 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President & CEO | Gift | G | 0.00 | 5,000 | 0 | 1,096,711 | 1.1 M to 1.1 M (-0.45 %) |
| Jan 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 15,000 | 95,100 | 0 | |
| Jan 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 16.73 | 15,000 | 250,959 | 1,045,055 | 1.1 M to 1 M (-1.42 %) |
| Jan 05 2012 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 15,000 | 95,100 | 1,060,055 | 1 M to 1.1 M (+1.44 %) |
| Dec 02 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 15,000 | 95,100 | 15,000 | |
| Dec 02 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 15.97 | 15,000 | 239,597 | 1,045,055 | 1.1 M to 1 M (-1.42 %) |
| Dec 02 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 15,000 | 95,100 | 1,060,055 | 1 M to 1.1 M (+1.44 %) |
| Nov 03 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 15,000 | 95,100 | 30,000 | |
| Nov 03 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 21.89 | 15,000 | 328,413 | 1,045,055 | 1.1 M to 1 M (-1.42 %) |
| Nov 03 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 15,000 | 95,100 | 1,060,055 | 1 M to 1.1 M (+1.44 %) |
| Oct 06 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 15,000 | 95,100 | 45,000 | |
| Oct 06 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 20.15 | 15,000 | 302,283 | 1,045,055 | 1.1 M to 1 M (-1.42 %) |
| Oct 06 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 15,000 | 95,100 | 1,060,055 | 1 M to 1.1 M (+1.44 %) |
| Sep 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 24,400 | 154,696 | 60,000 | |
| Sep 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 5,600 | 35,504 | 84,400 | |
| Sep 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 20.15 | 24,400 | 491,711 | 1,045,055 | 1.1 M to 1 M (-2.28 %) |
| Sep 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 24,400 | 154,696 | 1,069,455 | 1 M to 1.1 M (+2.33 %) |
| Sep 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 20.00 | 5,600 | 112,007 | 1,045,055 | 1.1 M to 1 M (-0.53 %) |
| Sep 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 5,600 | 35,504 | 1,050,655 | 1 M to 1.1 M (+0.54 %) |
| Sep 06 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 3.30 | 16,251 | 53,628 | 0 | |
| Sep 06 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 3.30 | 16,251 | 53,628 | 1,045,055 | 1 M to 1 M (+1.58 %) |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 15.46 | 293,532 | 4,538,005 | 293,532 | |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 15.46 | 6,468 | 99,995 | 6,468 | |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 60,000 | 0 | 1,028,804 | 968.8 K to 1 M (+6.19 %) |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 18,137 | 0 | 968,804 | 950.7 K to 968.8 K (+1.91 %) |
| Jul 01 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 15,000 | 95,100 | 90,000 | |
| Jul 01 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 20.66 | 15,000 | 309,866 | 950,667 | 965.7 K to 950.7 K (-1.55 %) |
| Jul 01 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 15,000 | 95,100 | 965,667 | 950.7 K to 965.7 K (+1.58 %) |
| Jun 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 9,000 | 57,060 | 105,000 | |
| Jun 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 20.01 | 9,000 | 180,071 | 950,667 | 959.7 K to 950.7 K (-0.94 %) |
| Jun 21 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 9,000 | 57,060 | 959,667 | 950.7 K to 959.7 K (+0.95 %) |
| Jun 13 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 1,000 | 6,340 | 114,000 | |
| Jun 13 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 20.00 | 1,000 | 20,000 | 950,667 | 951.7 K to 950.7 K (-0.11 %) |
| Jun 13 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 1,000 | 6,340 | 951,667 | 950.7 K to 951.7 K (+0.11 %) |
| May 20 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 6.34 | 5,000 | 31,700 | 0 | |
| May 20 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 6.34 | 5,000 | 31,700 | 950,667 | 945.7 K to 950.7 K (+0.53 %) |
| May 11 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 8.43 | 50,000 | 421,500 | 0 | |
| May 11 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 17.35 | 50,000 | 867,705 | 945,667 | 995.7 K to 945.7 K (-5.02 %) |
| May 11 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 8.43 | 50,000 | 421,500 | 995,667 | 945.7 K to 995.7 K (+5.29 %) |
| May 03 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 8.43 | 50,000 | 421,500 | 50,000 | |
| May 03 2011 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 17.43 | 50,000 | 871,355 | 945,667 | 995.7 K to 945.7 K (-5.02 %) |